Current stock page

Catalysts

IMNM Stock Catalysts

Earnings · Growth Drivers · Events · AIQ Catalyst

HealthcareBiotechnologyScore data as of Nov 13, 2026

IMNMImmunome, Inc.

Healthcare / Biotechnology

Relative Leader / Watch

Strong Relative Position

BearishEdge 8/10
$18.77+$0.07 (+0.37%)

Latest quote

  • Momentum
    45
  • Value
    —
  • Quality
    52
  • Risk resilience
    47
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

Stock Catalyst Board

Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.

Next earnings
Mar 2, 2027

Upcoming reporting date available for this company.

AIQ Catalyst
AIQ 48/100

Momentum 45/100 and sentiment — before the next covered event.

Recent coverage
4 articles

Updated Nov 15, 2026 · Sentiment 35.62%

Earnings History And Surprises

See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.

Earnings Expectations And Results

Compare what analysts expected with what the company reported across recent quarters.

Momentum 45/100AIQ Edge 8/10 Strong Relative Position
Beat rate
38%
3 of 8 reported periods
Average surprise
-8.5%
Across covered historical reports
Latest result
-22.2%
Nov 9, 2026
EPS estimate versus actual
Actual bars are colored by beat, inline result, or miss.
Earnings history
Report dateFiscal periodEPS estimateEPS actualEPS surpriseRevenue estimateRevenue actual
Nov 9, 2026—-$0.62-$0.76-22.2%$153.85K—
Aug 11, 2026—-$0.51-$0.65-26.5%$166.67K—
May 12, 2026—-$0.60-$0.48+20.0%$222.22K—
Mar 3, 2026—-$0.59-$0.75-27.1%$876.03K—
Nov 6, 2025—-$0.57-$0.65-14.0%$850K—
Aug 6, 2025—-$0.52-$0.50+3.8%$833.33K$4.02M
May 12, 2025—-$0.66-$0.52+21.2%$457.14K$2.93M
Mar 19, 2025—-$0.68-$0.84-23.5%$3.15M$2.74M

Analyst Forecast And Price Targets

Wall Street consensus, rating distribution, and the current 12-month target range.

Analyst ratings
Buy
16
Buy
1
Hold
12-month analyst target
$27.00
+43.85% versus current price
Based on 17 analyst observations. Targets are estimates, not predictions.
Low target
$24.00
+27.86% vs latest price
Average target
$27.00
+43.85% vs latest price
High target
$30.00
+59.83% vs latest price

Event Read

Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.

Current event setup

Event dateMar 2, 2027

Next known earnings or reporting date.

EPS estimate-$0.76

Current analyst expectation for the upcoming report.

Revenue estimate$142.86K

Current analyst expectation for the upcoming report.

Sentiment score—

News pressure around the setup.

Momentum score45

Where event reaction would show up first.

AIQ score48/100

Composite decision read before event confirmation.

Analyst context

Consensus
Buy
Analysts
17
Average target
$27.00
Target upside
43.85%
Target range
$24.00 - $30.00

News And Sentiment

Recent company coverage, scored where source sentiment is available.

Positive
4
Neutral
0
Negative
0
gurufocus.com · Oct 16, 2026

IMNM Initiated Coverage by William Blair -- Rating Set to Outperform

Immunome Inc (IMNM): Analyst Rating and Valuation Insights On October 1, 2026, William Blair initiated coverage of Immunome (IMNM) with an Outperform rating.

gurufocus.com · Oct 1, 2026

IMNM Initiated Coverage by Stifel -- Rated Hold with PT at $24.00

Immunome (IMNM) Analyst Rating Update On October 3, 2023, Immunome (IMNM) has been assigned a ”œHold” rating by analyst Dara Azar from Stifel, who initiat

gurufocus.com · Sep 30, 2026

Immunome (IMNM) Gains FDA IND Clearance for IM-1340 Targeting Advanced Solid Tumors

On September 30, 2026, Immunome Inc (NASDAQ: IMNM) announced that the U.S. Food and Drug Administration has authorized its Investigational New Drug (IND) applic

gurufocus.com · Sep 21, 2026

IMNM Initiates Coverage On Alliance Global Partners -- Rating Set to Buy

Immunome Inc: Analyst Ratings and Valuation Insights On September 21, 2026, Alliance Global Partners initiated coverage on Immunome (IMNM) with a rating of '

Open full news and sentiment

IMNM Catalysts FAQ

What are the next catalysts for IMNM stock?

IMNM's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.

What upcoming events could move IMNM stock?

Upcoming events that could move IMNM include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.

How could IMNM's next earnings report affect the stock?

IMNM's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.

What could drive IMNM stock higher?

IMNM could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.

What events could hurt IMNM stock?

IMNM could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.